41 – 50 of 4689
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
(
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
2024) In Cancer Causes and Control(
- Contribution to journal › Article
-
Mark
Pencil beam scanning proton therapy for mediastinal lymphomas in deep inspiration breath-hold : a retrospective assessment of plan robustness
(
- Contribution to journal › Article
-
Mark
A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE : Comparison of model implementations in SAAM II and MATLAB/SimBiology
(
- Contribution to journal › Article
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
2024) In BJU International(
- Contribution to journal › Article
-
Mark
Optimising External Beam Radiotherapy for Prostate Cancer. Advances in Treatment Planning
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (monograph)
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
-
Mark
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines : a clinical implementation study
2024) In Breast Cancer Research and Treatment(
- Contribution to journal › Article
-
Mark
In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
(
- Contribution to journal › Article
-
Mark
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
(
- Contribution to journal › Letter